Treatment of MUC1-positive prostate cancer cells with GO-201 lead to reduced cell proliferation and necrotic cell death, whereas no such effect was observed in MUC1-negative prostate cancer cells. The gene discussed is MUC1; the disease is prostate carcinoma.